Human-specific CHRFAM7A protects against radiotherapy-induced lacrimal gland injury by inhibiting the p38/JNK signalling pathway and oxidative stress.
Radiotherapy-induced lacrimal gland injury often causes dry eye. Oxidative stress and local...
Read More